These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 28484424)
1. Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation. Manousaki D; Deladoëy J; Geoffroy L; Olivier P Front Endocrinol (Lausanne); 2017; 8():84. PubMed ID: 28484424 [TBL] [Abstract][Full Text] [Related]
2. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study. Giménez M; Lara M; Conget I Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825 [TBL] [Abstract][Full Text] [Related]
3. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417 [TBL] [Abstract][Full Text] [Related]
4. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
5. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Sulli N; Shashaj B Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629 [TBL] [Abstract][Full Text] [Related]
6. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective. Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389 [TBL] [Abstract][Full Text] [Related]
7. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients]. Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes. Alemzadeh R; Parton EA; Holzum MK Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060 [TBL] [Abstract][Full Text] [Related]
9. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus. Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548 [TBL] [Abstract][Full Text] [Related]
10. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related]
11. Modern clinical management helps reducing the impact of type 1 diabetes in children. Scaramuzza AE; Zuccotti GV Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825 [TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. Potti LG; Haines ST J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588 [TBL] [Abstract][Full Text] [Related]
15. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus]. Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370 [TBL] [Abstract][Full Text] [Related]
17. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion. Pańkowska E; Szypowska A; Lipka M; Skórka A Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017 [TBL] [Abstract][Full Text] [Related]
19. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290 [TBL] [Abstract][Full Text] [Related]